Pension & Wealth Management Advisors’s Royalty Pharma RPRX Stock Holding History

Pension & Wealth Management Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.8K	Buy	+852	New	+$44.3K	0.01%	325

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIA

Caledonia Investments (Australia) Sydney NSW, Australia $2.93B AUM 37.21% 1-Year Est. Return

Pension & Wealth Management Advisors's RPRX Position: Q2 2026 in Review

Pension & Wealth Management Advisors opened a new position in Royalty Pharma (RPRX) in Q2 2026: 852 shares worth $47.8K. The stake represents 0.01% of the portfolio and ranks #325 among its holdings.

607 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Pension & Wealth Management Advisors held 852 shares of Royalty Pharma worth $47.8K as of Q2 2026.
Royalty Pharma was a new Pension & Wealth Management Advisors position in Q2 2026.
Royalty Pharma made up 0.01% of Pension & Wealth Management Advisors's portfolio in Q2 2026, its #325 holding.
607 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Pension & Wealth Management Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.